Cathie Wood’s ARK Invest Adjusts Portfolio: Boosts Biotech and DraftKings, Trims Shopify
Cathie Wood's ARK Invest made strategic portfolio adjustments on October 29, increasing exposure to biotech firms 10X Genomics and Pacific Biosciences while adding to its DraftKings stake. The MOVE signals conviction in genomics and digital entertainment sectors.
ARK sold 3,633 Shopify shares ahead of earnings, continuing its capital rotation into high-growth innovation themes. The firm's genomic ETF (ARKG) acquired $2.86 million worth of 10X Genomics shares, underscoring Wood's bullish thesis on precision medicine.